Table: Sapporo Clinical Lab -Q1 group results

Sapporo Clinical Laboratory

07/08/2020 07:30

Aug 7 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2020        Jun 30, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             4.07                4.43             17.23    
                 (-8.0 pct)          (+3.5 pct)       (-2.5 pct)  
  Operating        33 mln              267 mln          620 mln   
                 (-87.3 pct)        (+179.1 pct)      (-34.3 pct) 
  Recurring        39 mln              271 mln          635 mln   
                 (-85.4 pct)        (+152.7 pct)      (-35.4 pct) 
  Net            loss 1 mln            179 mln          407 mln   
                                    (+172.9 pct)      (-22.9 pct) 
  EPS           loss 0.39 yen         52.56 yen       119.03 yen  
  Ann Div                             10.00 yen        10.00 yen  
  -Q2 div                                NIL              NIL     
  -Q4 div                             10.00 yen        10.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T